|
|
|
|
DNA Isolation |
1 |
$75 |
1 x 83891; 1 x 83912 |
Shipping: $50 plus all shipping costs |
2 |
$50+ |
|
Specific Mutations (most genes on our list): 1-2 mutations |
3 |
$250 |
1 x 83891; 4 x 83894; 2 x 83898; 4 x 83904; 1 x 83912 |
Specific Deletion-Duplication Verification by qPCR |
3Q |
$250 |
1 x 83891; 4 x 83894; 2 x 83898; 1 x 83912 |
Specific Mutation (any gene not on our list) |
4 |
$350 |
1 x 83891; 4 x 83894; 2 x 83898; 4 x 83904; 1 x 83912 |
Prenatal Testing (2 mutations); includes MCC |
5 |
$1150 |
3 x 83891; 28 x 83894; 14 x 83898; 28 x 83904; 3 x 83912 |
Prenatal Testing (1 mutation); includes MCC |
6 |
$850 |
3 x 83891; 24 x 83894; 12 x 83898; 24 x 83904; 3 x 83912 |
Maternal Cell Contamination (MCC) |
7 |
$350 |
1 x 83891; 20 x 83894; 10 x 83898; 20 x 83904; 1 x 83912 |
aCGH: Deletion-Duplication Targeted Exonic Oligonucleotide Microarray (Includes Verification) |
|
|
|
1 Gene |
6000+ |
$750 |
1 x 83891; 1 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
2-3 Genes |
6000+ |
$1200 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 4 x 83912 |
4-5 Genes |
6000+ |
$1500 |
1 x 83891; 5 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 6 x 83912 |
6-10 Genes |
6000+ |
$2000 |
1 x 83891; 10 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 11 x 83912 |
Cardiomyopathies |
|
|
|
Arrhythmogenic Right Ventricular Dysplasia, ARVD |
|
|
|
4-Gene Sequencing Panel: PKP2, DSP, DSG2, DSC2 (can also be ordered separately) |
16 |
$2000 |
1 x 83891; 106 x 83894; 53 x 83898; 106 x 83904; 4 x 83912 |
Danon Disease, GSD IIB (X-linked), LAMP2 Sequencing |
22 |
$650 |
1 x 83891; 18 x 83894; 9 x 83898; 18 x 83904; 1 x 83912 |
Lamin A/C-Related Disorders |
|
|
|
LMNA Sequencing |
23 |
$750 |
1 x 83891; 22 x 83894; 11 x 83898; 22 x 83904; 1 x 83912 |
LMNA Del-Dup Targeted Exonic Microarray |
6023 |
$750 |
1 x 83891; 1 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
|
|
|
|
Factor II/Prothrombin Thrombophilia, PT (20210G>A) |
27 |
$175 |
1 x 83891, 1 x 83892, 2 x 83896, 1 x 83900, 2 x 83901, 1 x 83912 |
Factor V Leiden Thrombophilia, FV (R506Q) |
24 |
$175 |
1 x 83891, 1 x 83892, 2 x 83896, 1 x 83900, 2 x 83901, 1 x 83912 |
MTHFR Targeted Mutations (A233V, E429A) |
28 |
$175 |
1 x 83891, 1 x 83892, 4 x 83896, 1 x 83900, 2 x 83901, 1 x 83912 |
Cystic Fibrosis, CF, CFTR-Related Disorders |
|
|
|
CFTR 23-Mutation Panel |
14 |
$250 |
1 x 83891, 1 x 83892, 1 x 83900, 13 x 83901, 1 x 88384, 1 x 83912 |
CFTR Del-Dup Targeted Exonic Microarray |
6014 |
$750 |
1 x 83891; 1 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Developmental Delay or Autism |
|
|
|
FMR1-Related Disorders (Fragile X, FXTAS, POI) |
|
|
|
FMR1 CGG Repeats, FX (includes Southern Blot if positive) |
FX #46 |
$300 |
1 x 83891; 2 x 83892; 4 x 83894; 1 x 83896; 1 x 83897; 2 x 83898; 4 x 83904; 1 x 83912 |
FMR1 Del-Dup Targeted Exonic Microarray |
6046 |
$750 |
1 x 83891; 1 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
PTEN-Related Disorders |
|
|
|
PTEN Sequencing |
110 |
$950 |
1 x 83891; 20 x 83894; 10 x 83898; 20 x 83904; 1 x 83912 |
PTEN Del-Dup Targeted Exonic Microarray |
6110 |
$750 |
1 x 83891; 1 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Disorders of Sex Development |
|
|
|
Androgen Insensitivity Syndrome, AIS |
|
|
|
3-Gene Sequencing Panel (AR, SRY, WT1) |
37 |
$1500 |
1 x 83891; 42 x 83894; 21 x 83898; 42 x 83904; 3 x 83912 |
Androgen Receptor, AR Sequencing |
38 |
$1000 |
1 x 83891; 20 x 83894; 10 x 83898; 20 x 83904; 1 x 83912 |
XY Gonadal Dysgenesis, SRY Sequencing |
39 |
$250 |
1 x 83891; 2 x 83894; 1 x 83898; 2 x 83904; 1 x 83912 |
WT1-Related Disorders, WT1 Sequencing: Denys-Drash; Frasier; Wilms Tumor; Nephrotic Syndrome |
40 |
$750 |
1 x 83891; 20 x 83894; 10 x 83898; 20 x 83904; 1 x 83912 |
| WT1 Del-Dup, MLPA |
5040 |
$585 |
1 x 83891; 1x83900; 12 x 83901; 12 x 83914; 3 x 83909; 1x83912 |
Early Onset Encephalopathy |
|
|
|
Aicardi-Goutieres Syndrome, AGS |
|
|
|
AGS, 5-Gene Sequencing Panel (TREX1, RNASEH2B, RNASEH2C, RNASEH2A, SAMHD1) |
93 |
$1950 |
1 x 83891; 80 x 83894; 40 x 83898; 80 x 83904; 5 x 83912 |
AGS, 5-Gene Del-Dup Targeted Exonic Microarray (TREX1, RNASEH2B, RNASEH2C, RNASEH2A, SAMHD1) |
6093 |
$1500 |
1 x 83891; 5 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 6 x 83912 |
AGS Tier 1 |
|
|
|
2-Gene Sequencing Panel (TREX1, RNASEH2B) |
94 |
$900 |
1 x 83891; 26 x 83894; 13 x 83898; 26 x 83904; 2 x 83912 |
2-Gene Del-Dup Targeted Exonic Microarray (TREX1, RNASEH2B) |
6094 |
$1200 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 4 x 83912 |
AGS Tier 2 |
|
|
|
2-Gene Sequencing Panel (RNASEH2C, RNASEH2A) |
95 |
$900 |
1 x 83891; 24 x 83894; 12 x 83898; 24 x 83904; 2 x 83912 |
2-Gene Del-Dup Targeted Exonic Microarray (RNASEH2C, RNASEH2A) |
6095 |
$1200 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 4 x 83912 |
AGS Tier 3 |
|
|
|
SAMHD1 Sequencing |
123 |
$800 |
1 x 83891; 30 x 83894; 15 x 83898; 30 x 83904; 1 x 83912 |
SAMHD1 Del-Dup Targeted Exonic Microarray |
6123 |
$750 |
1 x 83891; 1 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
AGS Individual Genes |
|
|
|
TREX1 Sequencing |
96 |
$450 |
1 x 83891; 4 x 83894; 2 x 83898; 4 x 83904; 1 x 83912 |
TREX1 Del-Dup Targeted Exonic Microarray |
6096 |
$750 |
1 x 83891; 1 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
RNASEH2B Sequencing |
97 |
$650 |
1 x 83891; 22 x 83894; 11 x 83898; 22 x 83904; 1 x 83912 |
RNASEH2B Del-Dup Targeted Exonic Microarray |
6097 |
$750 |
1 x 83891; 1 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
RNASEH2C Sequencing |
98 |
$500 |
1 x 83891; 8 x 83894; 4 x 83898; 8 x 83904; 1 x 83912 |
RNASEH2C Del-Dup Targeted Exonic Microarray |
6098 |
$750 |
1 x 83891; 1 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
RNASEH2A Sequencing |
99 |
$600 |
1 x 83891; 16 x 83894; 8 x 83898; 16 x 83904; 1 x 83912 |
RNASEH2A Del-Dup Targeted Exonic Microarray |
6099 |
$750 |
1 x 83891; 1 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
SAMHD1 Sequencing |
123 |
$800 |
1 x 83891; 30 x 83894; 15 x 83898; 30 x 83904; 1 x 83912 |
SAMHD1 Del-Dup Targeted Exonic Microarray |
6123 |
$750 |
1 x 83891; 1 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
| Cystic Leukoencephalopathy |
|
|
|
| RNASET2 Sequencing |
252 |
$1250 |
1 x 83891; 18 x 83894; 9 x 83898; 18 x 83904; 1 x 83912 |
Fibroblast Growth Factor Receptor Disorders |
|
|
|
FGFR-Related Skeletal Dysplasias & Craniosynostoses (Syndromic & Isolated Coronal) |
|
|
|
FGFR, Three-Gene Sequencing Panel (FGFR1, FGFR2, FGFR3) |
241 |
$3200 |
1 x 83891; 86 x 83894; 43 x 83898; 86 x 83904; 3 x 83912 |
FGFR, Three-Gene Del-Dup Targeted Exonic Microarray (FGFR1+2+3) |
6241 |
$1200 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 4 x 83912 |
FGFR Individual Genes |
|
|
|
FGFR1 – Pfeiffer Syndrome, Osteoglophonic Dysplasia |
|
|
|
FGFR1 Sequencing |
128 |
$1200 |
1 x 83891; 26 x 83894; 13 x 83898; 26 x 83904; 1 x 83912 |
FGFR1 Del-Dup Targeted Exonic Microarray |
6128 |
$750 |
1 x 83891; 1 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
FGFR1 Exon-1 Sequencing for P252R Mutation – Pfeiffer |
234 |
$250 |
1 x 83891; 2 x 83894; 1 x 83898; 2 x 83904; 1 x 83912 |
FGFR2 – Crouzon, Jackson-Weiss, Beare-Stevenson, Apert, Pfeiffer |
|
|
|
FGFR2 Sequencing |
129 |
$1200 |
1 x 83891; 32 x 83894; 16 x 83898; 32 x 83904; 1 x 83912 |
FGFR2 Del-Dup Targeted Exonic Microarray |
6129 |
$750 |
1 x 83891; 1 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
FGFR2 Exon-3 Sequencing for S252W, P253R Mutations – Apert |
236 |
$250 |
1 x 83891; 2 x 83894; 1 x 83898; 2 x 83904; 1 x 83912 |
FGFR2 Exon-7 Sequencing for S372C, Y375C Mutations – Beare-Stevenson |
237 |
$250 |
1 x 83891; 2 x 83894; 1 x 83898; 2 x 83904; 1 x 83912 |
FGFR3 |
|
|
|
FGFR3 Sequencing of the whole gene |
130 |
$1200 |
1 x 83891; 28 x 83894; 14 x 83898; 28 x 83904; 1 x 83912 |
FGFR3 Del-Dup Targeted Exonic Microarray |
6130 |
$750 |
1 x 83891; 1 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
FGFR3 Tier 1, Sequencing of Exons 7, 9, 12, 14, 18 – Panel includes: Skeletal Dysplasias (Achondroplasia; Hypochondroplasia; Thanatophoric Dysplasia TD1/TD2; SADDAN) + Craniosynostoses (Crouzon with Acanthosis Nigricans; Muenke Syndrome) |
42 |
$500 |
1 x 83891; 10 x 83894; 5 x 83898; 10 x 83904; 1 x 83912 |
FGFR3 Tier 2, Add-on Sequencing after #42: All Except Exons 7, 9, 12, 14, 18 (Tiers 1+2 = Full FGFR3 Sequence, Test #130) |
142 |
$700 |
1 x 83891; 18 x 83894; 9 x 83898; 18 x 83904; 1 x 83912 |
| FGFR3 Exon-14 Sequencing for K650M Mutation – SADDAN |
45 |
$250 |
1 x 83891; 2 x 83894; 1 x 83898; 2 x 83904; 1 x 83912 |
FGFR3 Exon-9 Sequencing for A391E mutation – Crouzon with Acanthosis Nigricans |
44 |
$250 |
1 x 83891; 2 x 83894; 1 x 83898; 2 x 83904; 1 x 83912 |
FGFR3 Exon-7 Sequencing for P250R Mutation – Muenke |
43 |
$250 |
1 x 83891; 2 x 83894; 1 x 83898; 2 x 83904; 1 x 83912 |
FMR1-Related Disorders (Fragile X, FXTAS, POI) |
|
|
|
FMR1 Gene, CGG Repeats (includes Southern Blot if positive), FX |
46 |
$300 |
1 x 83891; 2 x 83892; 4 x 83894; 1 x 83896; 1 x 83897; 2 x 83898; 4 x 83904; 1 x 83912 |
FMR1 Del-Dup Targeted Exonic Microarray |
6046 |
$750 |
1 x 83891; 1 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Hearing Loss / Deafness |
|
|
|
Connexin 26 |
|
|
|
GJB2 Sequencing |
29 |
$450 |
1 x 83891; 4 x 83894; 2 x 83898; 4 x 83904; 1 x 83912 |
GJB2 Del-Dup Targeted Exonic Microarray |
6029 |
$750 |
1 x 83891; 1 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Connexin 30 |
|
|
|
GJB6 Common Deletion |
30 |
$350 |
1 x 83891; 3 x 83894; 3 x 83898; 1 x 83912 |
GJB6 Del-Dup Targeted Exonic Microarray |
6030 |
$750 |
1 x 83891; 1 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Pendred Syndrome |
|
|
|
SLC26A4 Sequencing |
31 |
$1100 |
1 x 83891; 36 x 83894; 18 x 83898; 36 x 83904; 1 x 83912 |
SLC26A4 Del-Dup Targeted Exonic Microarray |
6031 |
$750 |
1 x 83891; 1 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Waardenburg Syndrome |
|
|
|
4-Gene Sequencing Panel (PAX3, MITF, SOX10, EDNRB) |
32 |
$2400 |
1 x 83891; 68 x 83894; 34 x 83898; 68 x 83904; 4 x 83912 |
PAX3 Sequencing, Waardenburg Syndrome 1, 3, CDHS |
33 |
$650 |
1 x 83891; 18 x 83894; 9 x 83898; 18 x 83904; 1 x 83912 |
MITF Sequencing, Waardenburg Syndrome 2, Tietz |
34 |
$1000 |
1 x 83891; 30 x 83894; 15 x 83898; 30 x 83904; 1 x 83912 |
SOX10 Sequencing, Waardenburg Syndrome 4 |
35 |
$400 |
1 x 83891; 6 x 83894; 3 x 83898; 6 x 83904; 1 x 83912 |
EDNRB Sequencing, Waardenburg-Shah Syndrome |
36 |
$600 |
1 x 83891; 14 x 83894; 7 x 83898; 14 x 83904; 1 x 83912 |
Wolfram Syndrome 1/Wolframin, WFS1 Sequencing |
137 |
$950 |
1 x 83891; 20 x 83894; 10 x 83898; 20 x 83904; 1 x 83912 |
Immune Disorders |
|
|
|
Chronic Granulomatous Disease, CGD |
|
|
|
CYBB Sequencing, p91-PHOX |
151 |
$1500 |
1 x 83891; 26 x 83894; 13 x 83898; 26 x 83904; 1 x 83912 |
CYBA Sequencing, p22-PHOX |
152 |
$750 |
1 x 83891; 12 x 83894; 6 x 83898; 12 x 83904; 1 x 83912 |
| NCF2 Sequencing, p67-PHOX |
153 |
$1550 |
1 x 83891; 30 x 83894; 15 x 83898; 30 x 83904; 1 x 83912 |
| NCF4 Sequencing, p40-PHOX |
154 |
$1250 |
1 x 83891; 18 x 83894; 9 x 83898; 18 x 83904; 1 x 83912 |
Chediak-Higashi Syndrome, CHS1 (LYST) Sequencing |
104 |
$1750 |
1 x 83891; 104 x 83894; 52 x 83898; 104 x 83904; 1 x 83912 |
Iron Storage Disorders |
|
|
|
Hereditary Hemochromatosis, HFE (C282Y, H63D mutations) |
47 |
$150 |
1 x 83891; 3 x 83892; 3 x 83894; 2 x 83898; 1 x 83912 |
Limb Anomalies with Congenital Heart Malformation |
|
|
|
Duane Radial Ray Syndrome, SALL4 Sequencing |
49 |
$950 |
1 x 83891; 16 x 83894; 8 x 83898; 16 x 83904; 1 x 83912 |
Holt-Oram Syndrome |
|
|
|
TBX5 Sequencing |
50 |
$950 |
1 x 83891; 16 x 83894; 8 x 83898; 16 x 83904; 1 x 83912 |
TBX5 Del-Dup Targeted Exonic Microarray |
6050 |
$750 |
1 x 83891; 1 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Townes-Brock Syndrome, SALL1 Sequencing |
48 |
$950 |
1 x 83891; 16 x 83894; 8 x 83898; 16 x 83904; 1 x 83912 |
Metabolic Disorders |
|
|
|
3-Methyl-Crotonyl-CoA Carboxylase Def., 3MCC |
|
|
|
Two-Gene Sequencing Panel (MCCC1, MCCC2) |
52 |
$1500 |
1 x 83891; 34 x 83894; 17 x 83898; 34 x 83904; 2 x 83912 |
Two-Gene Del-Dup Targeted Exonic Microarray (MCCC1, MCCC2) |
6052 |
$1200 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 4 x 83912 |
MCCA, MCCC1 Sequencing |
53 |
$900 |
1 x 83891; 18 x 83894; 9 x 83898; 18 x 83904; 1 x 83912 |
MCCA, MCCC1 Del-Dup Targeted Exonic Microarray |
6053 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
MCCB, MCCC2 Sequencing |
54 |
$800 |
1 x 83891; 16 x 83894; 8 x 83898; 16 x 83904; 1 x 83912 |
MCCB, MCCC2 Del-Dup Targeted Exonic Microarray |
6054 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Biotinidase Deficiency |
|
|
|
BTD Sequencing |
127 |
$450 |
1 x 83891; 10 x 83894; 5 x 83898; 10 x 83904; 1 x 83912 |
BTD Del-Dup Targeted Exonic Microarray |
6127 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Glutaric Acidemia Type 1, GA1 |
|
|
|
GCDH Sequencing |
56 |
$525 |
1 x 83891; 18 x 83894; 9 x 83898; 18 x 83904; 1 x 83912 |
GCDH Del-Dup Targeted Exonic Microarray |
6056 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Glutaric Acidemia Type 2, GA2 (MADD, Multiple Acyl-CoA Dehydrogenase Deficiency) |
|
|
|
3-Gene Sequence Panel (ETFDH, ETFA, ETFB) |
57 |
$2400 |
1 x 83891; 54 x 83894; 27 x 83898; 54 x 83904; 3 x 83912 |
3-Gene Del-Dup Targeted Exonic Microarray (ETFDH, ETFA, ETFB) |
6057 |
$1200 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 4 x 83912 |
ETFDH Sequencing |
58 |
$1000 |
1 x 83891; 22 x 83894; 11 x 83898; 22 x 83904; 1 x 83912 |
ETFDH Del-Dup Targeted Exonic Microarray |
6058 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
ETFA Sequencing |
59 |
$850 |
1 x 83891; 20 x 83894; 10 x 83898; 20 x 83904; 1 x 83912 |
ETFA Del-Dup Targeted Exonic Microarray |
6059 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
ETFB Sequencing |
60 |
$550 |
1 x 83891; 12 x 83894; 6 x 83898; 12 x 83904; 1 x 83912 |
ETFB Del-Dup Targeted Exonic Microarray |
6060 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Glutaric Acidemia Type 3, GA3, C7orf10 Sequencing |
102 |
$1100 |
1 x 83891; 30 x 83894; 15 x 83898; 30 x 83904; 1 x 83912 |
Holocarboxylase Synthase Deficiency |
|
|
|
HCS Sequencing |
61 |
$725 |
1 x 83891; 20 x 83894; 10 x 83898; 20 x 83904; 1 x 83912 |
HCS Del-Dup Targeted Exonic Microarray |
6061 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Homocystinuria due to Cystathionine Beta-Synthase Deficiency |
|
|
|
CBS Sequencing |
62 |
$1200 |
1 x 83891; 30 x 83894; 15 x 83898; 30 x 83904; 1 x 83912 |
CBS Del-Dup Targeted Exonic Microarray |
6062 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Long Chain 3-Hydroxy-Acyl-CoA Dehydrogenase Deficiency, LCHAD |
|
|
|
HADHA Common Mutation (E510Q) |
63 |
$250 |
1 x 83891; 1 x 83892; 1 x 83894; 1 x 83898; 1 x 83912 |
HADHA Del-Dup Targeted Exonic Microarray |
6063 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Maple Syrup Urine Disease, MSUD |
|
|
|
4 Targeted Ashkenazi Mutations: BCKDHA Exon-9 (Y438N) and BCKDHB Exon-5 (R183P) + Exon-7 (G278S) + Exon-10 (E372X) |
100 |
$350 |
1 x 83891; 8 x 83894; 4 x 83898; 8 x 83904; 1 x 83912 |
Medium Chain Acyl-CoA Dehydrogenase Def., MCAD |
|
|
|
ACADM Common Mutation (K304E) |
64 |
$250 |
1 x 83891; 1 x 83898; 2 x 83904; 1 x 83912 |
ACADM Sequencing |
65 |
$1000 |
1 x 83891; 22 x 83894; 11 x 83898; 22 x 83904; 1 x 83912 |
ACADM Del-Dup Targeted Exonic Microarray |
6065 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Methylmalonic Acidemia, MMA |
|
|
|
3-Gene Sequencing Panel (MUT, MMAA, MMAB) |
66 |
$1500 |
1 x 83891; 52 x 83894; 26 x 83898; 52 x 83904; 3 x 83912 |
3-Gene Del-Dup Targeted Exonic Microarray (MUT, MMAA, MMAB) |
6066 |
$1200 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 4 x 83912 |
MUT Sequencing, Mutase Deficiency |
67 |
$960 |
1 x 83891; 24 x 83894; 12 x 83898; 24 x 83904; 1 x 83912 |
MUT Del-Dup Targeted Exonic Microarray |
6067 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
MMAA Sequencing |
68 |
$480 |
1 x 83891; 12 x 83894; 6 x 83898; 12 x 83904; 1 x 83912 |
MMAA Del-Dup Targeted Exonic Microarray |
6068 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
MMAB Sequencing |
69 |
$640 |
1 x 83891; 16 x 83894; 8 x 83898; 16 x 83904; 1 x 83912 |
MMAB Del-Dup Targeted Exonic Microarray |
6069 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Cobalamin C Deficiency, MMACHC Sequencing |
71 |
$320 |
1 x 83891; 8 x 83894; 4 x 83898; 8 x 83904; 1 x 83912 |
Cobalamin C Def., MMACHC Del-Dup Targeted Exonic Microarray |
6071 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
| Cobalamin D Deficiency, MMADHC (C2orf25) Sequencing |
251 |
$550 |
1 x 83891; 14 x 83894; 7 x 83898; 14 x 83904; 1 x 83912 |
Cobalamin F Deficiency, MMAF: LMBRD1 Sequencing |
242 |
$900 |
1 x 83891; 28 x 83894; 14 x 83898; 28 x 83904; 1 x 83912 |
Epimerase Deficiency, MCEE Sequencing |
72 |
$320 |
1 x 83891; 6 x 83894; 3 x 83898; 6 x 83904; 1 x 83912 |
Epimerase Deficiency, MCEE Del-Dup Targeted Exonic Microarray |
6072 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Propionic Acidemia |
|
|
|
2-Gene Sequencing Panel (PCCA, PCCB) |
77 |
$1800 |
1 x 83891; 76 x 83894; 38 x 83898; 76 x 83904; 2 x 83912 |
2-Gene Del-Dup Targeted Exonic Microarray (PCCA, PCCB) |
6077 |
$1200 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 4 x 83912 |
PCCA Sequencing |
78 |
$1100 |
1 x 83891; 48 x 83894; 24 x 83898; 48 x 83904; 1 x 83912 |
PCCA Del-Dup Targeted Exonic Microarray |
6078 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
PCCB Sequencing |
79 |
$700 |
1 x 83891; 28 x 83894; 14 x 83898; 28 x 83904; 1 x 83912 |
PCCB Del-Dup Targeted Exonic Microarray |
6079 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Sepiapterin Reductase Deficiency |
|
|
|
SPR Sequencing |
80 |
$400 |
1 x 83891; 6 x 83894; 3 x 83898; 6 x 83904; 1 x 83912 |
SPR Del-Dup Targeted Exonic Microarray |
6080 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Trimethylaminuria, TMAU (after positive biochemical testing) |
|
|
|
FMO3 Sequencing |
81 |
$600 |
1 x 83891; 14 x 83894; 7 x 83898; 14 x 83904; 1 x 83912 |
FMO3 Del-Dup Targeted Exonic Microarray |
6081 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Very Long Chain Acyl-CoA Dehydrogenase Deficiency, VLCAD |
|
|
|
ACADVL Sequencing |
82 |
$725 |
1 x 83891; 16 x 83894; 8 x 83898; 16 x 83904; 1 x 83912 |
ACADVL Del-Dup Targeted Exonic Microarray |
6082 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Mitochondrial Disorders |
|
|
|
Multiple Mitochondrial Dysfunctions Syndrome, MMDS |
|
|
|
| Fe-S Cluster Biogenesis Defects |
|
|
|
| BOLA3 Sequencing |
243 |
$550 |
1 x 83891; 8 x 83894; 4 x 83898; 8 x 83904; 1 x 83912 |
| NFU1 sequencing |
244 |
$950 |
1 x 83891; 16 x 83894; 8 x 83898; 16 x 83904; 1 x 83912 |
| PDH, Pyruvate Dehydrogenase Complex |
|
|
|
| PDHA1 Sequencing |
245 |
$1200 |
1 x 83891; 20 x 83894; 10 x 83898; 20 x 83904; 1 x 83912 |
POLG1-Related Disorders |
|
|
|
POLG1 Sequencing |
103 |
$1500 |
1 x 83891; 34 x 83894; 17 x 83898; 34 x 83904; 1 x 83912 |
POLG1 Del-Dup Targeted Exonic Microarray |
6103 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Multiple Congenital Anomalies |
|
|
|
Rubinstein-Taybi Syndrome, RTS |
|
|
|
2-Gene Sequencing Panel (CREBBP, EP300) |
111 |
$2500 |
1 x 83891; 120 x 83894; 60 x 83898; 120 x 83904; 2 x 83912 |
CREBBP Sequencing |
112 |
$1500 |
1 x 83891; 62 x 83894; 31 x 83898; 62 x 83904; 1 x 83912 |
EP300 Sequencing |
113 |
$1500 |
1 x 83891; 58 x 83894; 29 x 83898; 58 x 83904; 1 x 83912 |
Smith-Lemli-Opitz Syndrome, SLOS, DHCR7 Sequencing |
136 |
$490 |
1 x 83891; 14 x 83894; 7 x 83898; 14 x 83904; 1 x 83912 |
Neonatal Epilepsy |
|
|
|
Non-Ketotic Hyperglycinemia, Glycine Encephalopathy, NKH |
|
|
|
3-Gene Sequencing Panel (AMT, GLDC, GCSH) |
226 |
$1500 |
1 x 83891; 70 x 83894; 35 x 83898; 70 x 83904; 2 x 83912 |
3-Gene Del-Dup Targeted Exonic Microarray (AMT, GLDC, GCSH) |
6226 |
$1200 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 4 x 83912 |
AMT Sequencing |
74 |
$500 |
1 x 83891; 12 x 83894; 6 x 83898; 12 x 83904; 1 x 83912 |
AMT Del-Dup Targeted Exonic Microarray |
6074 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
GLDC Sequencing |
75 |
$950 |
1 x 83891; 48 x 83894; 24 x 83898; 48 x 83904; 1 x 83912 |
GLDC Del-Dup Targeted Exonic Microarray |
6075 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
GCSH Sequencing |
76 |
$400 |
1 x 83891; 10 x 83894; 5 x 83898; 10 x 83904; 1 x 83912 |
GCSH Del-Dup Targeted Exonic Microarray |
6076 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Pyridoxal-Phosphate-Dependent Neonatal Seizures |
|
|
|
PNPO Sequencing |
155 |
$450 |
1 x 83891; 10 x 83894; 5 x 83898; 10 x 83904; 1 x 83912 |
PNPO Del-Dup Targeted Exonic Microarray |
6155 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Pyridoxine-Dependent Neonatal Seizures, Antiquitin, ATQ-1 |
|
|
|
ALDH7A1 Sequencing |
55 |
$680 |
1 x 83891; 34 x 83894; 17 x 83898; 34 x 83904; 1 x 83912 |
ALDH7A1 Del-Dup Targeted Exonic Microarray |
6055 |
$750 |
1 x 83891; 3 x 88386; 2 x 83894; 1 x 83898; 2 x 83904; 2 x 83912 |
Pigmentation Disorders |
|
|
|
Albinism / Oculocutaneous Albinism |
|
|
|
Albinism Panel-Plus: 5-Gene Sequencing Panel (TYR, OCA2, TYRP1, SLC45A2, GPR143) + OCA2 2.7-kb Deletion |
146 |
$2950 |
1 x 83891; 120 x 83894; 60 x 83898; 118 x 83904; 6 x 83912 |
OCA1, TYR Sequencing |
87 |
$1000 |
1 x 83891; 18 x 83894; 9 x 83898; 18 x 83904; 1 x 83912 |
OCA2-Plus, OCA2 (P-Gene) Sequencing + 2.7-kb Deletion |
147 |
$1500 |
1 x 83891; 48 x 83894; 24 x 83898; 46 x 83904; 2 x 83912 |
OCA2 (P-Gene) Sequencing only |
88 |
$1500 |
1 x 83891; 46 x 83894; 23 x 83898; 46 x 83904; 1 x 83912 |
OCA2 (P-Gene) 2.7-kb Deletion only |
89 |
$350 |
1 x 83891; 2 x 83894; 1 x 83898; 1 x 83912 |
OCA3, TYRP1 Sequencing |
90 |
$1000 |
1 x 83891; 18 x 83894; 9 x 83898; 18 x 83904; 1 x 83912 |
OCA4, SLC45A2 (MATP) Sequencing |
91 |
$1000 |
1 x 83891; 18 x 83894; 9 x 83898; 18 x 83904; 1 x 83912 |
OA1 (X-Linked Ocular Albinism), GPR143 Sequencing |
92 |
$800 |
1 x 83891; 18 x 83894; 9 x 83898; 18 x 83904; 1 x 83912 |
Chediak-Higashi Syndrome, CHS1 (LYST) Sequencing |
104 |
$1750 |
1 x 83891; 104 x 83894; 52 x 83898; 104 x 83904; 1 x 83912 |
Hermansky-Pudlak Syndrome |
|
|
|
HPS1, Common Puerto Rican Mutation (1470_1486dup16) |
83 |
$250 |
1 x 83891; 1 x 83894; 1 x 83898; 1 x 83912 |
HPS3, Common Puerto Rican Mutation (339_4260del3904) |
85 |
$250 |
1 x 83891; 2 x 83894; 1 x 83898; 2 x 83904; 1 x 83912 |
HPS3, Common Ashkenazi Jewish Mutation (1163+1G>A) |
86 |
$250 |
1 x 83891; 2 x 83894; 1 x 83898; 2 x 83904; 1 x 83912 |
Piebaldism, Mast Cell Leukemia, GIST |
|
|
|
c-KIT Sequencing |
105 |
$900 |
1 x 83891; 34 x 83894; 17 x 83898; 34 x 83904; 1 x 83912 |
Vision Loss / Blindness / Eye Diseases |
|
|
|
Achromatopsia |
|
|
|
CNGA3 Sequencing, Achromatopsia 2 |
119 |
$595 |
1 x 83891; 18 x 83894; 9 x 83898; 18 x 83904; 1 x 83912 |
CNGB3 Sequencing, Achromatopsia 3 |
120 |
$850 |
1 x 83891; 32 x 83894; 16 x 83898; 32 x 83904; 1 x 83912 |
GNAT2 Sequencing, Achromatopsia 4 |
121 |
$595 |
1 x 83891; 16 x 83894; 8 x 83898; 16 x 83904; 1 x 83912 |
PDE6C Sequencing, Achromatopsia 5 |
126 |
$850 |
1 x 83891; 36 x 83894; 18 x 83898; 36 x 83904; 1 x 83912 |
Joubert Syndrome; Bardet-Biedl; Meckel; Senior-Loken; LCA |
|
|
|
CEP290 Sequencing |
107 |
$1800 |
1 x 83891; 96 x 83894; 48 x 83898; 96 x 83904; 1 x 83912 |
PAX6-Related Disorders: Isolated Aniridia, Anophthalmia, Gillespie |
|
|
|
PAX6 Sequencing |
148 |
$650 |
1 x 83891; 18 x 83894; 9 x 83898; 18 x 83904; 1 x 83912 |
| PAX6 Del-Dup, MLPA: WAGR (Wilms Tumor, Aniridia, Genitourinary Anomalies, Mental Retardation) |
5148 |
$495 |
1 x 83891; 1 x 83900; 13 x 83901; 13 x 83914; 3 x 83909; 1 x 83912 |
Stargardt; arRP; Age-Related Macular Degeneration; CORD3 |
|
|
|
ABCA4 Sequencing |
124 |
$1750 |
1 x 83891; 104 x 83894; 52 x 83898; 104 x 83904; 1 x 83912 |
New genes can be tested for the purpose of test development. |
|
|
Thank you for your business. We look forward to serving you and helping your patients. |